Vortioxetine Treatment for Anxiety Disorder: A Meta-Analysis Study.

CONCLUSION: This review supports the use of Vortioxetine for anxiety disorder. However, further long-term placebo-control observational study or a post market survey would help in strengthening the evidence for this treatment modality. PMID: 29149828 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29149828?dopt=Abstract

Source: Current Drug Targets - November 17, 2017 Category: Drugs & Pharmacology Authors: Yee A, Ng CG, Seng LH Tags: Curr Drug Targets Source Type: research